PT Indofarma Tbk
IDX:INAF.JK
126 (IDR) • At close July 1, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) IDR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 523,599.087 | 1,144,108.231 | 2,901,986.533 | 1,715,587.654 | 1,359,175.25 | 1,592,979.941 | 1,631,317.499 | 1,674,702.722 | 1,621,898.668 | 1,381,436.578 | 1,337,498.192 | 1,156,050.257 | 1,203,466.971 | 1,047,918.156 | 1,125,055.391 | 1,478,585.255 | 1,273,162.479 | 1,026,675.534 | 684,039.649 |
| Cost of Revenue
| 695,556.553 | 1,254,216.942 | 2,450,332.549 | 1,314,987.874 | 1,108,815.136 | 1,308,760.118 | 1,348,504.215 | 1,337,793.754 | 1,291,844.221 | 1,069,010.402 | 999,930.881 | 788,154.612 | 807,282.613 | 729,453.843 | 820,419.578 | 1,145,182.421 | 983,208.145 | 770,718.532 | 484,768.636 |
| Gross Profit
| -171,957.465 | -110,108.711 | 451,653.984 | 400,599.781 | 250,360.113 | 284,219.823 | 282,813.284 | 336,908.968 | 330,054.447 | 312,426.177 | 337,567.311 | 367,895.645 | 396,184.358 | 318,464.313 | 304,635.813 | 333,402.834 | 289,954.334 | 255,957.002 | 199,271.013 |
| Gross Profit Ratio
| -0.328 | -0.096 | 0.156 | 0.234 | 0.184 | 0.178 | 0.173 | 0.201 | 0.203 | 0.226 | 0.252 | 0.318 | 0.329 | 0.304 | 0.271 | 0.225 | 0.228 | 0.249 | 0.291 |
| Reseach & Development Expenses
| 592.427 | 552.77 | 763.952 | 501.235 | 306.173 | 326.873 | 2,420.698 | 3,192.785 | 3,640.525 | 1,031.636 | 1,588.38 | 1,080.824 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 0 | 42,940.336 | 45,749.651 | 41,158.084 | 31,802.651 | 30,896.859 | 28,766.503 | 35,359.404 | 28,761.955 | 31,954.411 | 57,821.781 | 40,894.06 | 110,641.805 | 92,084.63 | 83,146.834 | 80,026.484 | 77,485.572 | 66,212.433 | 57,565.255 |
| Selling & Marketing Expenses
| 0 | 48,523.192 | 43,733.28 | 44,960.774 | 36,441.019 | 50,485.558 | 68,025.838 | 87,076.029 | 93,256.131 | 95,841.436 | 106,676.878 | 87,042.179 | 193,583.851 | 169,931.964 | 175,580.196 | 190,356.9 | 167,759.11 | 127,511.668 | 106,625.105 |
| SG&A
| 278,152.057 | 91,463.528 | 89,482.931 | 86,118.858 | 68,243.67 | 81,382.417 | 96,792.341 | 122,435.434 | 122,018.086 | 127,795.848 | 164,498.66 | 127,936.239 | 304,225.656 | 262,016.594 | 258,727.029 | 270,383.385 | 245,244.681 | 193,724.101 | 164,190.36 |
| Other Expenses
| -59,877.228 | 246,790.741 | 305,402.642 | 212,233.548 | 172,380.343 | -7,242.141 | -1,975.736 | -602.324 | 1,560.567 | 3,425.392 | -3,437.482 | 1,446.132 | -3,884.842 | -9,092.143 | 565.629 | -8,938.368 | -8,637.491 | -6,973.206 | 202.856 |
| Operating Expenses
| 338,621.711 | 338,254.269 | 394,885.573 | 298,352.406 | 240,624.014 | 303,575.903 | 281,952.347 | 299,680.746 | 271,727.487 | 271,746.62 | 353,997.906 | 284,385.856 | 304,225.656 | 262,016.594 | 258,727.029 | 270,383.385 | 245,244.681 | 193,724.101 | 164,190.36 |
| Operating Income
| -510,579.177 | -479,544.148 | 51,979.235 | 87,656.548 | 16,936.782 | 25,910.151 | 2,458.485 | 37,228.222 | 58,326.96 | 40,679.556 | -16,430.596 | 78,441.061 | 91,958.702 | 56,447.72 | 45,908.783 | 63,019.45 | 44,709.653 | 62,232.901 | 35,080.653 |
| Operating Income Ratio
| -0.975 | -0.419 | 0.018 | 0.051 | 0.012 | 0.016 | 0.002 | 0.022 | 0.036 | 0.029 | -0.012 | 0.068 | 0.076 | 0.054 | 0.041 | 0.043 | 0.035 | 0.061 | 0.051 |
| Total Other Income Expenses Net
| -158,930.041 | -38,013.713 | -43,206.036 | -69,574.946 | -7,190.812 | -20,197.368 | -59,275.454 | -56,149.56 | -44,151.822 | -33,277.92 | -46,602.152 | -16,708.959 | -36,755.927 | -36,038.882 | -33,242.777 | -53,153.028 | -22,635.522 | -22,169.201 | -19,041.639 |
| Income Before Tax
| -669,509.218 | -517,557.862 | 8,773.199 | 18,081.602 | 9,745.969 | -25,298.215 | -56,816.969 | -18,921.338 | 14,175.138 | 7,401.636 | -63,032.747 | 61,732.102 | 55,202.776 | 20,408.838 | 12,666.006 | 9,866.422 | 22,074.131 | 40,063.701 | 16,039.013 |
| Income Before Tax Ratio
| -1.279 | -0.452 | 0.003 | 0.011 | 0.007 | -0.016 | -0.035 | -0.011 | 0.009 | 0.005 | -0.047 | 0.053 | 0.046 | 0.019 | 0.011 | 0.007 | 0.017 | 0.039 | 0.023 |
| Income Tax Expense
| 51,490.858 | -89,070.19 | 46,344.44 | 18,051.581 | 1,784.003 | 7,438.267 | -10,532.21 | -1,553.938 | 7,609.43 | 6,236.811 | -8,810.152 | 19,346.987 | 18,283.459 | 7,862.17 | 10,540.273 | 4,834.466 | 10,997.11 | 24,822.997 | 6,444.25 |
| Net Income
| -720,993.176 | -428,487.672 | -37,571.241 | 27.581 | 7,960.963 | -32,735.901 | -46,282.94 | -17,366.641 | 6,566.936 | 1,166.073 | -54,222.344 | 42,384.957 | 36,919.317 | 12,546.644 | 2,125.638 | 5,031.899 | 11,076.807 | 15,240.675 | 9,594.743 |
| Net Income Ratio
| -1.377 | -0.375 | -0.013 | 0 | 0.006 | -0.021 | -0.028 | -0.01 | 0.004 | 0.001 | -0.041 | 0.037 | 0.031 | 0.012 | 0.002 | 0.003 | 0.009 | 0.015 | 0.014 |
| EPS
| -232.63 | -138.25 | -12.12 | 0.009 | 2.57 | -10.56 | -14.93 | -5.6 | 2.12 | 2.02 | -17.5 | 13.68 | 11.93 | 4.05 | 0.69 | 0.02 | 3.57 | 4.92 | 3.1 |
| EPS Diluted
| -232.63 | -138.25 | -12.12 | 0.009 | 2.57 | -10.56 | -14.93 | -5.6 | 2.12 | 2.02 | -17.5 | 13.68 | 11.93 | 4.05 | 0.69 | 0.02 | 3.57 | 4.92 | 3.1 |
| EBITDA
| -482,943.028 | -440,575.152 | 71,480.822 | 101,652.49 | 24,718.91 | -9,482.702 | 22,143.023 | 44,450.956 | 62,540.114 | 51,273.749 | -39,811.305 | 85,144.269 | 103,999.718 | 59,732.654 | 51,440.323 | 39,319.014 | 38,146.171 | 59,186.523 | 32,920.307 |
| EBITDA Ratio
| -0.922 | -0.385 | 0.025 | 0.059 | 0.018 | -0.006 | 0.014 | 0.027 | 0.039 | 0.037 | -0.03 | 0.074 | 0.086 | 0.057 | 0.046 | 0.027 | 0.03 | 0.058 | 0.048 |